Settlement Prevents Contingent Payment Of Litigation Royalty
Client Alert | 1 min read | 04.24.06
In Parental Guide of Texas, Inc. v. Thompson, Inc . (No. 05-1493; April 21, 2006), the Federal Circuit affirms the district court's grant of summary judgment that Thompson did not owe Parental Guide a contingent payment under a Release and License Agreement (“Agreement”).
During a previous lawsuit, Parental Guide and Thompson reached a settlement and entered into the Agreement. In the Agreement, Thompson was obligated to make a contingent payment of a “Litigation Royalty” if there was a favorable determination of the lawsuit. The parties defined the “Litigation Royalty” as “the lowest per unit reasonable royalty, if any, as expressly determined in the Lawsuit in accordance with the law applicable to 35 U.S.C. § 284, by the final, irrevocable, and nonappealable order in the Lawsuit.”
Because the Agreement referenced section 284, the Federal Circuit determines that the “Litigation Royalty” would be a reasonable royalty that was determined by a judge or jury. In this case, however, the parties agreed to a royalty rate in their settlement, without a judge or jury making a reasonable royalty determination. Accordingly, the Federal Circuit determines that there is no “Litigation Royalty,” and thus there can be no contingent payment.
Insights
Client Alert | 4 min read | 09.16.26
CMS Offers Guidance as Scrutiny Rises Over ABA Therapy in Medicaid
Between 2021 and 2025, Medicaid spending on ABA therapy grew six times faster than the number of children who received services, making it one of the fastest-growing areas of Medicaid expenditure, according to CMS. On August 4, 2026, CMS released a toolkit to help state Medicaid and CHIP agencies strengthen their programs and limit fraud, waste, and abuse tied to increased demand for ABA therapy. In 2025, Medicaid spent about $10 billion on ABA and related therapy services for children with ASD — a dramatic increase from the $2 billion spent in 2021.
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
